sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), Delivery Platform (Over-The-Wire (OTW) Balloon Catheter, and Rapid Exchange (RX) / Monorail Balloon Catheter), Compliance (Semi-Compliant, and Non-Compliant), Balloon Material (Polyolefin Copolymer (POC), Polyethylene (PE), and Polyethylene Terephthalate (PET)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product...

Home / Categories / Healthcare
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), Delivery Platform (Over-The-Wire (OTW) Balloon Catheter, and Rapid Exchange (RX) / Monorail Balloon Catheter), Compliance (Semi-Compliant, and Non-Compliant), Balloon Material (Polyolefin Copolymer (POC), Polyethylene (PE), and Polyethylene Terephthalate (PET)) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Percutaneous Transluminal Coronary Angioplasty (PTCA)...
Report Code
RO1/113/1231

Publish Date
01/Aug/2017

Pages
165
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing ageing population and changing lifestyle of people
3.4.1.2. Technological advancements
3.4.1.3. Changes in FDA policy
3.4.1.4. Constant rise in incidences of heart disease

3.4.2. Restraints

3.4.2.1. Availability of alternative therapies such as tissue transplantation, bypass surgery, and medicines
3.4.2.2. Complications associated with balloon catheters

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging nations
3.4.3.2. Rise in demand for minimally-invasive surgeries

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL PTCA BALLOON CATHETERS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. NORMAL BALLOON CATHETERS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. DRUG ELUTING BALLOON CATHETER

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CUTTING BALLOON CATHETER

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SCORING BALLOON CATHETER

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GLOBAL PTCA BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. OVER-THE-WIRE (OTW) BALLOON CATHETER

5.2.1. Market size and forecast

5.3. RAPID EXCHANGE(RX)/ MONORAIL BALLOON CATHETER

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL PTCA BALLOON CATHETERS MARKET, BY COMPLIANCE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. SEMI-COMPLIANT

6.2.1. Market size and forecast

6.3. NON-COMPLIANT

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL PTCA BALLOON CATHETERS MARKET, BY BALLOON MATERIAL

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. POLYOLEFIN COPOLYMER (POC)

7.2.1. Market size and forecast

7.3. POLYETHYLENE (PE)

7.3.1. Market size and forecast

7.4. POLYETHYLENE TEREPHTHALATE (PET)

7.4.1. Market size and forecast

CHAPTER 8 PTCA BALLOON CATHETERS MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany
8.3.5. France
8.3.6. UK
8.3.7. Italy
8.3.8. Spain
8.3.9. Rest of Europe

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan
8.4.5. China
8.4.6. India
8.4.7. Australia
8.4.8. South Korea
8.4.9. Rest of Asia-Pacific

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Brazil
8.5.5. South Africa
8.5.6. Saudi Arabia
8.5.7. Rest of LAMEA

CHAPTER 9 COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments

9.2. B. BRAUN MELSUNGEN AG

9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments

9.3. BIOTRONIK SE & CO. KG

9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Key strategic moves and developments

9.4. BOSTON SCIENTIFIC CORPORATION

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves and developments

9.5. C. R. BARD, INC.

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments

9.6. CARDINAL HEALTH, INC.

9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves and developments

9.7. MEDTRONIC PLC

9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments

9.8. MICROPORT SCIENTIFIC CORPORATION

9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments

9.9. TERUMO CORPORATION

9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. THE SPECTRANETICS CORPORATION

9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com